Sophomer
1 known investors
Sophomer s.r.o. is an academic startup developing SophoMer™ F10, a fully synthetic polymer designed to replace bovine serum albumin as a nonspecific binding blocker in immunochemical assays. It targets developers of in vitro diagnostic (IVD) immunology diagnostics, combining immunoassay and polymer chemistry expertise.
Investors · 1
Frequently asked questions
- What does Sophomer do?
- Sophomer s.r.o. is an academic startup developing SophoMer™ F10, a fully synthetic polymer designed to replace bovine serum albumin as a nonspecific binding blocker in immunochemical assays. It targets developers of in vitro diagnostic (IVD) immunology diagnostics, combining immunoassay and polymer chemistry expertise.
- Who are Sophomer's investors?
- Sophomer's investors include Biotech Investments S.R.O.